Close

Lilly's (LLY) donanemab receives U.S. FDA's Breakthrough Therapy designation for treatment of Alzheimer's disease

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 4/24/2024

1. TSLA
2. ENPH
3. TXN
4. SPOT
5. BA
6. V
7. IBM
8. KMB
9. META
10. GM


Go back to Lilly's (LLY) donanemab receives U.S. FDA's Breakthrough Therapy designation for treatment of Alzheimer's disease
Lilly (Eli) & Co. (NYSE: LLY) Delayed: 732.20 -13.49 (1.81%)
Previous Close $745.69    52 Week High $88.16 
Open $752.64    52 Week Low $67.88 
Day High $752.64    P/E 169.49 
Day Low $728.79    EPS $4.32 
Volume 2,053,293